With respect to C677T polymorphism, a meta-analysis by Jin et al. [15] found that MTHFR C677T polymorphism was associated with an increased HCC risk in an overdominant model, however, they only included 10 eligible studies in the meta-analysis, which make their conclusions questionable. This evidence concerns the gene MTHFR and hepatocellular carcinoma.